# ZFYVE9

## Overview
ZFYVE9 is a gene that encodes the protein zinc finger FYVE-type containing 9, commonly referred to as SARA (Smad Anchor for Receptor Activation). This protein is categorized as an adaptor protein and plays a pivotal role in the transforming growth factor beta (TGF-β) signaling pathway. It facilitates the recruitment of receptor-regulated SMAD proteins to the TGF-β receptor complex, which is essential for their phosphorylation and subsequent nuclear translocation, thereby influencing gene expression related to cell growth, differentiation, and development (Bakkebø2012SARA). ZFYVE9 is primarily localized in the cytoplasm and endosomes, where it interacts with SMAD proteins and other signaling components, underscoring its role in mediating cellular responses to TGF-β (Esteves2012Protein). Despite its significant role in TGF-β signaling, ZFYVE9 is not indispensable for Smad activation in all cellular contexts, indicating a degree of functional redundancy or context-specific activity (Bakkebø2012SARA).

## Structure


## Function
ZFYVE9, also known as SARA (Smad Anchor for Receptor Activation), is a protein involved in the transforming growth factor beta (TGF-β) signaling pathway. It functions as an adaptor protein, facilitating the recruitment of receptor-regulated SMAD proteins (R-Smads) to the TGF-β receptor complex, which is crucial for their phosphorylation and subsequent nuclear translocation. This process is essential for the regulation of gene expression related to cell growth, differentiation, and development (Bakkebø2012SARA).

Despite its proposed role in TGF-β signaling, studies have shown that ZFYVE9 is not essential for TGF-β-induced Smad activation, nuclear translocation, or target gene induction in certain cell types, such as HeLa cells. This suggests that while ZFYVE9 may facilitate these processes, it is not indispensable for TGF-β signaling in all contexts (Bakkebø2012SARA).

ZFYVE9 is primarily active in the cytoplasm and endosomes, where it interacts with SMAD proteins and potentially other components of the TGF-β signaling pathway. Its activity in these cellular compartments underscores its role in mediating signal transduction processes that influence cellular responses to TGF-β (Esteves2012Protein).

## Clinical Significance
ZFYVE9 has been implicated in several diseases and conditions due to its role in cellular signaling pathways. Mutations or alterations in the expression of ZFYVE9 have been associated with aortic dissection (AD) in a Chinese population. The gene was identified as a novel candidate associated with AD, although its specific role in the disease remains to be fully understood (Wang202099Case). In Turner syndrome, ZFYVE9 is linked to aortic dilatation, suggesting its involvement in cardiovascular abnormalities observed in this condition (Trolle2016Widespread).

In the context of cancer, ZFYVE9 has been identified as harboring rare germline mutations in first-degree relatives of familial pancreatic cancer patients. These mutations may contribute to increased susceptibility to pancreatic ductal adenocarcinoma, highlighting the gene's potential role in cancer predisposition (Tan2021Whole). Additionally, ZFYVE9 has been implicated in obesity-related pathways through its association with body mass index (BMI) in genome-wide association studies, suggesting a potential link to metabolic disorders (Hägg2015Genebased). Despite these associations, the precise clinical significance of ZFYVE9 mutations and their impact on specific diseases require further investigation.

## Interactions
ZFYVE9, also known as SARA (Smad Anchor for Receptor Activation), is involved in several protein interactions that are crucial for its function in cellular signaling and trafficking. ZFYVE9 interacts with SMAD2 and SMAD3, facilitating their recruitment to the TGF-beta receptor complex, which is essential for their phosphorylation and subsequent signaling activities (Chang2014The). This interaction is mediated through the Smad-binding domain (SBD) of ZFYVE9, which binds to unphosphorylated SMAD2 and SMAD3 (Chang2014The).

ZFYVE9 also interacts with phosphatidylinositol 3-phosphate (PtdIns(3)P) through its FYVE domain, which is critical for its localization to early endosomes. This localization is important for its role in endosomal trafficking and TGF-beta signaling (Itoh2002The; Hu2002SARA). The FYVE domain's interaction with PtdIns(3)P is a common feature among FYVE domain-containing proteins, facilitating their endosomal localization (Itoh2002The).

In addition to its role in TGF-beta signaling, ZFYVE9 has been shown to interact with the giant ubiquitin ligase HERC2, indicating a potential role in intracellular protein trafficking and transport (Galligan2014Proteomic). These interactions highlight the multifaceted role of ZFYVE9 in cellular processes.


## References


[1. (Hägg2015Genebased) Sara Hägg, Andrea Ganna, Sander W. Van Der Laan, Tonu Esko, Tune H. Pers, Adam E. Locke, Sonja I. Berndt, Anne E. Justice, Bratati Kahali, Marten A. Siemelink, Gerard Pasterkamp, David P. Strachan, Elizabeth K. Speliotes, Kari E. North, Ruth J.F. Loos, Joel N. Hirschhorn, Yudi Pawitan, and Erik Ingelsson. Gene-based meta-analysis of genome-wide association studies implicates new loci involved in obesity. Human Molecular Genetics, 24(23):6849–6860, September 2015. URL: http://dx.doi.org/10.1093/hmg/ddv379, doi:10.1093/hmg/ddv379. This article has 55 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1093/hmg/ddv379)

[2. (Wang202099Case) Zanxin Wang, Xianmian Zhuang, Bailang Chen, Junmin Wen, Fang Peng, Xiling Liu, and Minxin Wei. 99-case study of sporadic aortic dissection by whole exome sequencing indicated novel disease-associated genes and variants in chinese population. BioMed Research International, 2020:1–12, October 2020. URL: http://dx.doi.org/10.1155/2020/7857043, doi:10.1155/2020/7857043. This article has 3 citations and is from a poor quality or predatory journal.](https://doi.org/10.1155/2020/7857043)

[3. (Esteves2012Protein) Sara L.C. Esteves, Sara C. Domingues, Odete A.B. da Cruz e Silva, Margarida Fardilha, and Edgar F. da Cruz e Silva. Protein phosphatase 1α interacting proteins in the human brain. OMICS: A Journal of Integrative Biology, 16(1–2):3–17, February 2012. URL: http://dx.doi.org/10.1089/omi.2011.0041, doi:10.1089/omi.2011.0041. This article has 35 citations and is from a peer-reviewed journal.](https://doi.org/10.1089/omi.2011.0041)

[4. (Trolle2016Widespread) Christian Trolle, Morten Muhlig Nielsen, Anne Skakkebæk, Philippe Lamy, Søren Vang, Jakob Hedegaard, Iver Nordentoft, Torben Falck Ørntoft, Jakob Skou Pedersen, and Claus Højbjerg Gravholt. Widespread dna hypomethylation and differential gene expression in turner syndrome. Scientific Reports, September 2016. URL: http://dx.doi.org/10.1038/srep34220, doi:10.1038/srep34220. This article has 109 citations and is from a peer-reviewed journal.](https://doi.org/10.1038/srep34220)

[5. (Galligan2014Proteomic) Jeffrey T. Galligan, Gustavo Martinez-Noël, Verena Arndt, Sebastian Hayes, Thomas W. Chittenden, J. Wade Harper, and Peter M. Howley. Proteomic analysis and identification of cellular interactors of the giant ubiquitin ligase herc2. Journal of Proteome Research, 14(2):953–966, December 2014. URL: http://dx.doi.org/10.1021/pr501005v, doi:10.1021/pr501005v. This article has 44 citations and is from a peer-reviewed journal.](https://doi.org/10.1021/pr501005v)

[6. (Hu2002SARA) Yang Hu, Jen-Zen Chuang, Kai Xu, Timothy G. McGraw, and Ching-Hwa Sung. Sara, a fyve domain protein, affects rab5-mediated endocytosis. Journal of Cell Science, 115(24):4755–4763, December 2002. URL: http://dx.doi.org/10.1242/jcs.00177, doi:10.1242/jcs.00177. This article has 56 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1242/jcs.00177)

[7. (Bakkebø2012SARA) Maren Bakkebø, Kanutte Huse, Vera I. Hilden, Lise Forfang, June H. Myklebust, Erlend B. Smeland, and Morten P. Oksvold. Sara is dispensable for functional tgf‐β signaling. FEBS Letters, 586(19):3367–3372, July 2012. URL: http://dx.doi.org/10.1016/j.febslet.2012.07.027, doi:10.1016/j.febslet.2012.07.027. This article has 28 citations and is from a peer-reviewed journal.](https://doi.org/10.1016/j.febslet.2012.07.027)

[8. (Chang2014The) Huang-Ming Chang, Yu-Ying Lin, Pei-Chun Tsai, Chung-Tiang Liang, and Yu-Ting Yan. The fyve domain of smad anchor for receptor activation (sara) is required to prevent skin carcinogenesis, but not in mouse development. PLoS ONE, 9(8):e105299, August 2014. URL: http://dx.doi.org/10.1371/journal.pone.0105299, doi:10.1371/journal.pone.0105299. This article has 3 citations and is from a peer-reviewed journal.](https://doi.org/10.1371/journal.pone.0105299)

[9. (Tan2021Whole) Ming Tan, Klaus Brusgaard, Anne‐Marie Gerdes, Michael Bau Mortensen, Sönke Detlefsen, Ove B. Schaffalitzky de Muckadell, and Maiken Thyregod Joergensen. Whole genome sequencing identifies rare germline variants enriched in cancer related genes in first degree relatives of familial pancreatic cancer patients. Clinical Genetics, 100(5):551–562, August 2021. URL: http://dx.doi.org/10.1111/cge.14038, doi:10.1111/cge.14038. This article has 6 citations and is from a peer-reviewed journal.](https://doi.org/10.1111/cge.14038)

[10. (Itoh2002The) Fumiko Itoh, Nullin Divecha, Lenny Brocks, Lauran Oomen, Hans Janssen, Jero Calafat, Susumu Itoh, and Peter ten Dijke. The fyve domain in smad anchor for receptor activation (sara) is sufficient for localization of sara in early endosomes and regulates tgf‐β/smad signalling. Genes to Cells, 7(3):321–331, March 2002. URL: http://dx.doi.org/10.1046/j.1365-2443.2002.00519.x, doi:10.1046/j.1365-2443.2002.00519.x. This article has 127 citations and is from a peer-reviewed journal.](https://doi.org/10.1046/j.1365-2443.2002.00519.x)